Piccart MJ - Search Results

1

Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing.

Gancberg D, Järvinen T, di Leo A, Rouas G, Cardoso F, Paesmans M, Verhest A, Piccart MJ, Isola J, Larsimont D. Gancberg D, et al. Among authors: piccart mj. Breast Cancer Res Treat. 2002 Jul;74(2):113-20. doi: 10.1023/a:1016146130767. Breast Cancer Res Treat. 2002. PMID: 12186371

2

History of brain and epidural metastases from breast cancer in relation with the disease evolution outside the central nervous system.

Dethy S, Piccart MJ, Paesmans M, van Houtte P, Klastersky J. Dethy S, et al. Among authors: piccart mj. Eur Neurol. 1995;35(1):38-42. doi: 10.1159/000117087. Eur Neurol. 1995. PMID: 7737245

3

Taxoid compounds in breast cancer: current status and future prospects.

Piccart MJ. Piccart MJ. Cancer Treat Res. 1995;78:185-207. doi: 10.1007/978-1-4615-2007-8_9. Cancer Treat Res. 1995. PMID: 8595143 Review. No abstract available.

4

Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Trivedi S, Piccart M, Muquardt C, Gilot N, Hadiy S, Patel D, Leclercq G. Trivedi S, et al. Breast Cancer Res Treat. 1996;40(3):231-41. doi: 10.1007/BF01806811. Breast Cancer Res Treat. 1996. PMID: 8883965

5

Future perspectives of docetaxel (Taxotere) in front-line therapy.

Piccart MJ, Di Leo A. Piccart MJ, et al. Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-27-S10-33. Semin Oncol. 1997. PMID: 9275004 Review.

6

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

de Valeriola D, Awada A, Roy JA, Di Leo A, Biganzoli L, Piccart M. de Valeriola D, et al. Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003. Drugs. 1997. PMID: 9279502 Review.

7

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.

Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, Di Leo A, Piccart M, Verhest A, Larsimont D. Lespagnard L, et al. Int J Cancer. 1999 Jun 21;84(3):309-14. doi: 10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3. Int J Cancer. 1999. PMID: 10371352

8

Paclitaxel activity, dose, and schedule: data from phase III trials in metastatic breast cancer.

Di Leo A, Piccart MJ. Di Leo A, et al. Among authors: piccart mj. Semin Oncol. 1999 Jun;26(3 Suppl 8):27-32. Semin Oncol. 1999. PMID: 10403471 Review.

9

[Therapeutic update on cancer of the breast].

Awada A, Leo AD, Piccart MJ. Awada A, et al. Among authors: piccart mj. Bull Cancer. 2000 Jan;87(1):49-62. Bull Cancer. 2000. PMID: 10673632 Free article. Review. French. No abstract available.

10

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

Di Leo A, Crown J, Nogaret JM, Duffy K, Bartholomeus S, Dolci S, Rowan S, O'Higgins N, Paesmans M, Larsimont D, Riva A, Piccart MJ. Di Leo A, et al. Among authors: piccart mj. Ann Oncol. 2000 Feb;11(2):169-75. doi: 10.1023/a:1008345432342. Ann Oncol. 2000. PMID: 10761751 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters